Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years.
- DOI
- 10.1136/jnnp-2025-337367
- Published
- 2026 Jun 12
- Container
- Journal of neurology, neurosurgery, and psychiatry
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jnnp-2025-337367,
title = {Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years.},
author = {Butzkueven H and Kappos L and Wiendl H and Trojano M and Spelman T and Greco A and Sun Z and Lasky T and TOP Investigators},
year = {2026},
journal = {Journal of neurology, neurosurgery, and psychiatry},
doi = {10.1136/jnnp-2025-337367},
url = {https://doi.org/10.1136/jnnp-2025-337367}
}RIS
TY - JOUR TI - Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years. AU - Butzkueven H AU - Kappos L AU - Wiendl H AU - Trojano M AU - Spelman T AU - Greco A AU - Sun Z AU - Lasky T AU - TOP Investigators PY - 2026 JO - Journal of neurology, neurosurgery, and psychiatry DO - 10.1136/jnnp-2025-337367 UR - https://doi.org/10.1136/jnnp-2025-337367 ER -
APA
H, B., L, K., H, W., M, T., T, S., A, G., Z, S., T, L., & Investigators, T. (2026). Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years.. Journal of neurology, neurosurgery, and psychiatry. https://doi.org/10.1136/jnnp-2025-337367
Source records
- pubmed · retrieved 2026-09-26T19:45:00.503Z